X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (168) 168
hematology (165) 165
index medicus (138) 138
male (129) 129
female (128) 128
aged (121) 121
middle aged (119) 119
oncology (103) 103
mutation (98) 98
aged, 80 and over (92) 92
adult (86) 86
prognosis (83) 83
genetic aspects (76) 76
myelofibrosis (66) 66
janus kinase 2 - genetics (58) 58
primary myelofibrosis - genetics (51) 51
research (50) 50
gene mutations (48) 48
risk factors (42) 42
adolescent (41) 41
jak2 (40) 40
polycythemia-vera (39) 39
leukemia (38) 38
essential thrombocythemia (34) 34
survival (33) 33
health aspects (32) 32
mutations (29) 29
myelodysplastic syndromes (29) 29
myeloproliferative disorders (29) 29
myeloproliferative neoplasms (29) 29
young adult (29) 29
survival analysis (28) 28
diagnosis (26) 26
dna mutational analysis (26) 26
primary myelofibrosis - mortality (26) 26
polycythemia vera - genetics (25) 25
myeloproliferative disorders - genetics (23) 23
receptors, thrombopoietin - genetics (22) 22
phenotype (21) 21
mutation - genetics (19) 19
physiological aspects (19) 19
proto-oncogene proteins - genetics (19) 19
acute myeloid-leukemia (18) 18
jak2v617f (18) 18
janus kinase 2 (18) 18
primary myelofibrosis (18) 18
repressor proteins - genetics (18) 18
calreticulin - genetics (17) 17
care and treatment (17) 17
chronic myelomonocytic leukemia (17) 17
cohort studies (17) 17
myeloproliferative (17) 17
survival rate (17) 17
leukemia, myelomonocytic, chronic - genetics (16) 16
myelodysplastic syndromes - genetics (16) 16
nuclear proteins - genetics (16) 16
primary myelofibrosis - pathology (16) 16
retrospective studies (16) 16
abridged index medicus (15) 15
analysis (15) 15
asxl1 (15) 15
follow-up studies (15) 15
myeloid metaplasia (15) 15
anemia (14) 14
bone marrow - pathology (14) 14
disorders (14) 14
neoplasms (14) 14
thrombocythemia, essential - genetics (14) 14
alleles (13) 13
article (13) 13
disease progression (13) 13
disease-free survival (13) 13
international working group (13) 13
polycythemia (13) 13
classification (12) 12
isocitrate dehydrogenase - genetics (12) 12
karyotyping (12) 12
neoplasms. tumors. oncology. including cancer and carcinogens (12) 12
polycythemia vera (12) 12
primary myelofibrosis - drug therapy (12) 12
correspondence (11) 11
kaplan-meier estimate (11) 11
leukemia, myelomonocytic, chronic - mortality (11) 11
myelodysplastic syndrome (11) 11
point mutation (11) 11
primary myelofibrosis - diagnosis (11) 11
protein-tyrosine kinases - genetics (11) 11
tyrosine kinase jak2 (11) 11
age factors (10) 10
development and progression (10) 10
karyotype (10) 10
original article (10) 10
polymerase chain reaction (10) 10
bone-marrow (9) 9
gene expression (9) 9
multivariate analysis (9) 9
original (9) 9
phosphoproteins - genetics (9) 9
prevalence (9) 9
primary myelofibrosis - complications (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


LEUKEMIA, ISSN 0887-6924, 07/2014, Volume 28, Issue 7, pp. 1472 - 1477
Calreticulin (CALR) mutations were recently described in JAK2 and MPL unmutated primary myelofibrosis (PMF) and essential thrombocythemia. In the current... 
PREDICTS | survival | MYELOPROLIFERATIVE NEOPLASMS | prognosis | TUMORS | CELL-DEATH | CALRETICULIN EXPOSURE | LEUKEMIA-FREE SURVIVAL | ONCOLOGY | myeloproliferative | DISEASE | ENDOPLASMIC-RETICULUM | CALR | MUTATIONS | HEALTH | JAK2 | HEMATOLOGY
Journal Article
Leukemia, ISSN 0887-6924, 09/2013, Volume 27, Issue 9, pp. 1861 - 1869
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2010, Volume 363, Issue 12, pp. 1189 - 1190
To the Editor: Erythrocytosis occurring in association with a subnormal serum erythropoietin level is indicative of underlying erythropoietin-independent... 
MEDICINE, GENERAL & INTERNAL | PREVALENCE | Polycythemia - genetics | Proteins - genetics | Phenotype | DNA Mutational Analysis | Humans | Janus Kinase 2 - genetics | Codon, Nonsense | Mutation, Missense | Bone marrow | Mutation | Lymphocytes | Pathogenesis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 10, pp. 908 - 919
Imetelstat, a telomerase inhibitor, induced complete or partial responses in 21% of patients with refractory myelofibrosis. In some patients, reversal of... 
MEDICINE, GENERAL & INTERNAL | POLYCYTHEMIA-VERA | THERAPY | RNA | CONSENSUS | MYELOPROLIFERATIVE NEOPLASMS | TETRAHYMENA | TERMINAL TRANSFERASE | MUTATIONS | CANCER | INTERNATIONAL WORKING GROUP | Niacinamide - analogs & derivatives | Fibrosis - drug therapy | Transaminases - drug effects | Humans | Middle Aged | Male | Indoles - administration & dosage | Polycythemia Vera - complications | DNA Mutational Analysis | Bone Marrow Cells - drug effects | Female | Primary Myelofibrosis - drug therapy | Drug Administration Schedule | Bone Marrow Cells - pathology | Janus Kinase 2 - genetics | Niacinamide - adverse effects | Primary Myelofibrosis - etiology | Remission Induction | Niacinamide - administration & dosage | Pilot Projects | Primary Myelofibrosis - genetics | Indoles - adverse effects | Aged | Infusions, Intravenous | Mutation | Telomerase - antagonists & inhibitors | Thrombocythemia, Essential - complications | Myelosuppression | Care and treatment | Usage | Dosage and administration | Myelofibrosis | Telomerase | Telomerase inhibitors | Alkaline phosphatase | Inhibitor drugs | Intravenous administration | Telomerase reverse transcriptase | RNA-directed DNA polymerase | Body weight | Bilirubin | Kinases | Janus kinase 2 | Bone marrow | Janus kinase | Remission | Drug dosages | Neutropenia | Spleen | Thrombocytopenia | Risk groups | Cell division | Ribonucleic acid--RNA | Patients | Bone cancer | Fibrosis | Aspartate aminotransferase
Journal Article
Leukemia, ISSN 0887-6924, 02/2012, Volume 26, Issue 2, pp. 280 - 288
Journal Article